CNR2 and Alzheimer disease: In particular, CB2 is upregulated in microglia during neurodegenerative and neuroinflammatory diseases such as AD [11–13], multiple sclerosis [14], PD [15], and ischemia [16–19], and is also known to be associated with microglial activity [20].